Topics

Bayer seeks approval to treat children with blockbuster drug Xarelto

04:36 EDT 8 Jul 2019 | Reuters

Bayer will apply for approval to make its blockbuster blood thinner Xarelto available for treating children, the German company said on Monday, after a study showed strong efficacy and safety in children with thromboembolism.

Original Article: Bayer seeks approval to treat children with blockbuster drug Xarelto

NEXT ARTICLE

More From BioPortfolio on "Bayer seeks approval to treat children with blockbuster drug Xarelto"

Quick Search

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Pediatrics
Pediatrics is the general medicine of childhood. Because of the developmental processes (psychological and physical) of childhood, the involvement of parents, and the social management of conditions at home and at school, pediatrics is a specialty. With ...